envelope, occurs by budding through intracellular membranes.
Viral particles are transported in cytoplasmic vesicles through
the secretory pathway before they are released by exocytosis
(Daep
et al
., 2014; Leyssen
et al
., 2000).
Transmission
Zika virus disease is caused by an RNA virus transmitted to
humans by the Aedes aegypti species. Up to eighty per cent of
infections are asymptomatic (Duffy
et al
., 2009). Symptomatic
infections are characterised by a self-limiting febrile illness of
4–7 days duration accompanied
by maculopapular rash,
arthralgia, conjunctivitis, myalgia and headache. Zika virus
has not been noted
to cause death in the past, nor has it been
linked to intra-uterine infections and congenital CNS
anomalies. Zika virus infection
can be confirmed by direct
detection of Zika virus RNA or specific viral antigens in
clinical specimens. There are no validated assays for serology.
More information on Zika virus disease can be found in the
previous risk assessments (European
Centre for Disease
Prevention and Control, 2014; European Centre for Disease
Prevention and Control, 2015) and in the ECDC
factsheet for
health professionals (Kuno
et al
., 1998)
Zika virus is spread to people primarily through the bite
of an infected
Aedes
species mosquito (
Ae. aegypti
and
Ae. albopictus
).
A pregnant woman can pass Zika virus to her fetus
during pregnancy or around the time of birth. We are
studying how Zika affects pregnancies.
To date, there are no reports
of infants getting Zika
through breastfeeding. Because of the benefits of
breastfeeding, mothers are encouraged to breastfeed
even in areas where Zika virus is found.
Dostları ilə paylaş: